Quick radiation after chemo for early breast cancer
Part of Cancer, Skin clinical trials.
This trial tests a shorter, more intense course of radiation to the whole breast after chemotherapy in women age 60 or older with early-stage breast cancer. It is designed for those who had a lumpectomy and are at higher risk based on genetic tests like Mammaprint or Oncotype.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 60 or older with invasive breast cancer (stage T1-T3) and no cancer in lymph nodes
- Had a lumpectomy (breast-conserving surgery) and negative margins (at least 2 mm clear)
- You have had or will have chemotherapy (before or after surgery)
- You have a high-risk result from a genetic test (Mammaprint or Oncotype DX)
- No prior radiation to the chest or breast, no breast implant or expander, and you haven't had a mastectomy
- No evidence that the cancer has spread to distant parts of the body
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter, more targeted course of daily radiation for early-stage breast cancer. The radiation plan is adjusted each day to better fit your body, which may reduce side effects.
This trial tests a short, more intense radiation schedule for women with certain breast cancer types or who are under 40. It aims to reduce treatment time while still targeting the whole breast and any high-risk areas.
This trial tests a shorter, more intense course of daily radiation therapy (called ultra hypo-fractionation) given after lumpectomy for early-stage breast cancer. The goal is to reduce the number of treatment visits while keeping the same high level of effectiveness and safety.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This Phase 2 trial tests a shorter, focused radiation treatment after breast surgery, either alone or with an extra targeted boost. It’s for people with low-risk breast cancer and no spread to distant organs, aiming to keep results while reducing treatment time and side effects.
This trial tests shorter radiation schedules for people with breast cancer that has spread to lymph nodes or is high-risk. It aims to find a shorter course of radiation that is just as effective after surgery.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.